[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:liver-fibrosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":94,"states":95},"Liver Fibrosis",13,9,[8,16,23,29,36,42,48,54,60,66,73,79,86],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07610837","Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis",[12],"Phase 2","RECRUITING","2026-08-26T02:15:37.042762Z","2026-05-29T15:36:40.229381Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06632444","LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH\u002FMASH Who Have Moderate or Advanced Liver Fibrosis",[20],"Phase 3","2026-08-26T02:18:52.966503Z","2026-05-05T02:43:29.514193Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05526144","Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans",[12],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:29.659734Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06374875","Fibrosis Lessens After Metabolic Surgery",[33],"Phase 4","2026-08-26T02:16:46.147215Z","2026-05-05T02:43:29.501896Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT05028829","Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk",[12],"2026-08-26T02:15:26.669629Z","2026-05-05T02:43:28.282869Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT07495332","Siemens Biomarker Multi-modality",[],"2026-08-26T02:16:26.411851Z","2026-05-05T02:35:31.708019Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT07122700","Evaluation of Non-Invasive Tests for Metabolic Liver Disease",[],"2026-08-26T02:15:09.079045Z","2026-05-13T02:55:06.656773Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06592820","Endoscopic Ultrasound Shear Wave Elastography Study",[],"2026-08-26T02:19:01.741747Z","2026-05-13T02:55:06.552998Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT01757730","Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues",[],"2026-08-26T02:19:21.761002Z","2026-05-13T02:55:06.076782Z",{"nct_id":67,"title":68,"phases":69,"status":70,"updated_at":71,"content_modified":72},"NCT06797596","Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.",[],"NOT_YET_RECRUITING","2026-08-26T02:18:24.494016Z","2026-05-13T02:55:06.578937Z",{"nct_id":74,"title":75,"phases":76,"status":70,"updated_at":77,"content_modified":78},"NCT07634939","Liver Micro Flow - MRI",[],"2026-08-26T02:18:17.007929Z","2026-06-14T18:39:22.253083Z",{"nct_id":80,"title":81,"phases":82,"status":83,"updated_at":84,"content_modified":85},"NCT06867731","Endosonographic Shear Wave Elastography to Assess Liver and Splenic Fibrosis",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:06.150683Z","2026-06-16T05:54:07.783442Z",{"nct_id":87,"title":88,"phases":89,"status":91,"updated_at":92,"content_modified":93},"NCT06348563","AGED Diagnostics Liver Disease Assessment",[90],"Early Phase 1","UNKNOWN","2026-08-03T03:12:56.078888Z","2026-05-05T02:43:27.174735Z",[],[96,100,104,107,111,114,117],{"state":97,"count":98,"slug":99},"Ohio",5,"ohio",{"state":101,"count":102,"slug":103},"Florida",4,"florida",{"state":105,"count":102,"slug":106},"Texas","texas",{"state":108,"count":109,"slug":110},"Arizona",3,"arizona",{"state":112,"count":109,"slug":113},"Massachusetts","massachusetts",{"state":115,"count":109,"slug":116},"Missouri","missouri",{"state":118,"count":109,"slug":119},"North Carolina","north-carolina"]